Statement of Need / Program Overview
Often referred to as a “silent epidemic,” osteoporosis is a global problem that is growing in significance as the worldwide population increases and continues to age. It is a serious public health concern in terms of incidence, healthcare costs and complications associated with the disease. Osteoporosis is characterized by low bone mineral density (BMD) which consequently leads to an increased risk for fractures, most commonly of the hip, spine and wrist. The loss of bone mass and strength is typically asymptomatic, thus many individuals are not aware that they have osteoporosis until a fracture occurs. Although low BMD confers an increased risk for fracture, most fractures occur in postmenopausal women and elderly men at moderate risk. Occurrence of an initial fracture has been demonstrated to be a major risk factor for new fractures. Vertebral fractures can lead to back pain, loss of height, kyphosis, immobility, and may also have a profound impact on quality of life and activities of daily living. The goals of osteoporosis treatment are to reduce bone loss, prevent fractures, control pain, and prevent disability. Despite attempts to increase awareness of the magnitude and consequences of osteoporosis and recommendations for screening and treatment from multiple groups, the disease remains under-detected and under-treated in the United States. There is also a need to examine the current evidence on treatment efficacy and outcomes for all treatment options for VCFs in order to advise patients on appropriate therapy for their individual situation.
Agenda
Welcome
Jeanne M. Huddleston, MD
Lecture: Overview of Consensus Guidelines for Osteoporosis Screening for Patients Who Should Undergo BMD Screening
Jeanne M. Huddleston, MD
Lecture: Ensuring Correct Diagnosis of VCFs: Signs, Symptoms and Tests
Mark Dekutoski, MD
Discussion: Practical Tips for Prevention and Diagnosis
Moderator: Jeanne M. Huddleston, MD
Panel: All faculty
Discussion: Best Practices for Communication Between Healthcare Team Members for At-risk Osteoporosis Patients During Their Continuum of Care
Moderator: Mark Dekutoski, MD
Panel: All faculty
Lecture: Pharmacologic Treatments and Lifestyle Changes for Osteoporosis Prevention and Management
Ann E. Kearns, MD, PhD
Lecture: Interventional Treatment Options for Patients with VCFs: When to Refer, Treatment Options, and Outcomes
Jonathan M. Morris, MD
Discussion: Treatment Options
Moderator: Mark Dekutoski, MD
Panel: All faculty
Concluding Comments
Mark Dekutoski, MD
Media
Internet, video with slides.
